Patricia Tabernero
Biographic Data
| ID | 9800068 |
|---|---|
| NAME | Patricia Tabernero |
| GIVEN NAMES | Patricia |
| FAMILY NAME | Tabernero |
| SIGNATURE | TABERNERO P |
| AFFILIATIONS | Universidad de Alcalá |
| ORCID | 0000-0002-1015-6207 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Estimating the prevalence of poor-quality anti-TB medicines
OBJECTIVES: Tuberculosis (TB) remains a major global public health problem, especially with the recent emergence of multidrug-resistant TB and extensively drug-resistant TB. There has been little consideration of the extent of substandard and falsified (SF) TB medicines as drivers of resistance. We assessed the evidence on the prevalence of SF anti-TB medicines and discussed their public health impact. MATERIALS/METHODS: We searched Web of Scienc…
No prominent works on this page.
Estimating the prevalence of poor-quality anti-TB medicines
OBJECTIVES: Tuberculosis (TB) remains a major global public health problem, especially with the recent emergence of multidrug-resistant TB and extensively drug-resistant TB. There has been little consideration of the extent of substandard and falsified (SF) TB medicines as drivers of resistance. We assessed the evidence on the prevalence of SF anti-TB medicines and discussed their public health impact. MATERIALS/METHODS: We searched Web of Scienc…
Environmental health (1 works) · Ethambutol (1 works) · Isoniazid (1 works) · Medicine (1 works) · Pathology (1 works) · Pharmaceutical Economics and Policy (1 works) · Pharmaceutical Quality and Counterfeiting (1 works) · Pharmaceutical studies and practices (1 works) · Public health (1 works) · Pyrazinamide (1 works)